Related by context. All words. (Click for frequent words.) 70 Overactive Bladder 69 Retinopathy 69 Critical Limb Ischemia 69 Eye Diseases 69 Age Related Macular 68 diabetic retinopathy 68 Rheumatoid Arthritis RA 68 Diabetic Neuropathy 67 Nonalcoholic Fatty Liver Disease 67 Hepatic Encephalopathy 67 Cognitive Impairment 67 Lupus Nephritis 67 Acute Heart Failure 67 Central Retinal Vein 67 Malignant Melanoma 67 Wet AMD 66 Allergic Rhinitis 66 Chronic Sinusitis 66 Autoimmune Disease 66 Atopic Dermatitis 66 Treating Chronic 66 Early Diagnosis 66 Benign Prostatic Hyperplasia 66 Rheumatoid Arthritis Patients 66 choroidal neovascularization 66 Surgical Procedures 66 occlusion CRVO 66 Inflammatory Diseases 66 Ischemic Stroke 66 proliferative retinopathy 66 Asthma COPD 66 Mouse Model 66 Diabetic Patients 66 Treatment Reduces 66 Ischemic 66 Cataract Surgery 66 Venous Thromboembolism 65 Chronic Kidney Disease 65 Breast Cancer Recurrence 65 Critical Limb Ischemia CLI 65 Chronic Heart Failure 65 Iron Overload 65 Clinical Outcome 65 Slow Progression 65 Non Alcoholic Fatty 65 Pulmonary Arterial Hypertension 65 Renal Cell Carcinoma 65 Beta Blockers 65 Patients Receiving 65 cataracts glaucoma 65 Juvenile Idiopathic Arthritis 65 Interstitial Cystitis 65 Catheter Associated 65 Bronchiectasis 65 Advanced Melanoma 65 Periodontitis 65 Systemic Sclerosis 65 Hypercholesterolemia 65 Metabolic Disease 65 Comorbidities 65 Immune Mediated 65 Knee Osteoarthritis 65 Gastric Cancer 64 Urinary Incontinence 64 Mild Cognitive Impairment 64 Patient Outcomes 64 Laryngeal Cancer 64 Uterine Fibroids 64 Severe Asthma 64 Adenomas 64 Clinical Trial Results 64 Neuroprotective Effects 64 neovascular AMD 64 Surgical Treatment 64 Hepatocellular Carcinoma 64 Vascular Disease 64 Chronic Hepatitis B 64 proliferative diabetic retinopathy 64 Eye Disease 64 Carotid Stenting 64 Fracture Risk 64 macular edema secondary 64 Heart Failure Patients 64 Diabetic Macular Edema 64 Metabolic Disorder 64 Periodontal Disease 64 Autoimmune Diseases 64 AA Amyloidosis 64 Acute Ischemic Stroke 64 Diabetic Foot Ulcer 64 retinal vein occlusion RVO 64 Gene Linked 64 Hepatitis C Virus 64 diabetic macular edema 64 Fibrosis 64 Septic Shock 64 macular degeneration diabetic retinopathy 64 Colorectal Adenomas 64 Preclinical Models 64 Macular Degeneration 64 Degeneration AMD 64 Angioedema 64 Chronic Lymphocytic Leukemia 64 Microplasmin 64 PsA 64 Renal Cancer 64 Keratoconus 64 Chronic Constipation 64 Prematurity ROP 64 Improve Survival 64 Renal Artery 64 Pooled Analysis 64 Benign Prostatic Hyperplasia BPH 64 psoriatic arthritis PsA 63 Chronic Bronchitis 63 Fibromyalgia Syndrome 63 Investigational Treatment 63 Prospective Randomized 63 Treatment Shows Promise 63 Catheter Ablation 63 diabetic macular edema DME 63 Peripheral Vascular Disease 63 Metastatic Prostate Cancer 63 Genes Linked 63 Low Incidence 63 Prognostic Value 63 Sjögren syndrome 63 Prostate Cancer Patients 63 Minimally Invasive Treatment 63 prospective multicenter study 63 Inflammatory Markers 63 LHON 63 Dupuytren Contracture 63 Multiple Myeloma Patients 63 Coronary Artery Bypass Graft 63 Cognitive Deficits 63 Patients Treated With 63 Keratitis 63 Improves Outcomes 63 Drug Shows Promise 63 Squamous Cell Carcinoma 63 Solid Tumors 63 ACE Inhibitors 63 Cardiotoxicity 63 Macular 63 Fungal Infections 63 Diabetic Foot Ulcers 63 Genes Identified 63 Invasive Breast Cancer 63 Diabetes Complications 63 neovascular 63 Breast Cancers 63 Retinitis Pigmentosa RP 63 Onychomycosis 63 Subtypes 63 Treatment Outcome 63 Cognitive Problems 63 Secondary Hyperparathyroidism 63 Chronic HCV 63 Renal Failure 63 Acute Decompensated Heart Failure 63 macular degeneration glaucoma 63 glaucoma cataracts 63 anterior uveitis 63 Vertebral Fractures 63 Insulin Resistance 63 Peripheral Arterial 63 Kidney Function 63 Brain Metastases 63 Skin Lesions 63 Severe Sepsis 63 Peripheral Artery Disease 63 Neurodegenerative 63 glaucoma macular degeneration 63 Aortic Dissection 63 Obstructive Sleep Apnea 63 acetonide FA 63 Hyperlipidemia 63 Left Ventricular 63 Epithelium 63 Phenotype 63 Aneurysm Repair 63 Non Invasive Treatment 63 Carotid Endarterectomy 62 Initiates Clinical Trial 62 Chronic Myeloid Leukemia 62 Genetic Markers 62 Disease Progression 62 Renal Function 62 Neovascular AMD 62 Subgroup Analysis 62 diabetic retinopathy DR 62 Adenoma 62 TTR amyloidosis 62 Occlusive Disease 62 Hepatocellular Carcinoma HCC 62 Prediabetes 62 JAK Inhibitor 62 Fabry Disease 62 Malignancies 62 hyperphenylalaninemia HPA due 62 Treatment Resistant 62 HCV Protease Inhibitor 62 Cardiac Function 62 Myocardial Ischemia 62 Clostridium difficile Infection 62 Tyrosine Kinase Inhibitor 62 retinal diseases 62 pathologic myopia 62 Autologous Stem Cell Transplantation 62 Rhinosinusitis 62 Acute Renal Failure 62 Often Misdiagnosed 62 Emerging Therapies 62 Shows Efficacy 62 Liver Failure 62 Prolongs Survival 62 Neovascular Age Related Macular 62 Leber Hereditary Optic Neuropathy 62 Iron Deficiency 62 Chronic Rhinosinusitis 62 Pulmonary Hypertension 62 Lung Injury 62 NOMID 62 Stem Cell Treatment 62 Follicular Lymphoma 62 Therapeutic Potential 62 Cardiovascular Outcomes 62 Phase III Clinical Trial 62 Tyrosine Kinase Inhibitors 62 Phase 2b Clinical Trial 62 Antitumor Activity 62 Placebo Controlled Trial 62 Randomized Study 62 Inflammatory Disease 62 Lowers Risk 62 Castration Resistant Prostate Cancer 62 Gene Mutation 62 Coronary Angiography 62 prematurity Stargardt disease 62 Myelodysplastic Syndrome 62 Chronic Prostatitis 62 Aggressive Reduction 62 AMD diabetic retinopathy 62 cytomegalovirus infection 62 Neuropathic Pain 62 Diagnostic Criteria 62 Predict Risk 62 Diabetic Nephropathy 62 Oral Fingolimod 62 Gastrointestinal Stromal Tumors 62 Imaging Technique 62 Hormone Receptor Positive 62 Patients Treated 62 Maven Semantic 62 Novel Treatments 62 Left Ventricular Hypertrophy 62 Treatment Options 62 Relapsing Remitting Multiple Sclerosis 62 Meets Primary Endpoint 62 Genetic Variation 62 Hospitalized Patients 62 Hip Fracture 62 Cerebrospinal Fluid 62 Chronic Renal Failure 62 Diabetic Eye 62 Clinical Trial Data 62 Treated Patients 62 Clinical Guideline 62 Myelodysplastic Syndromes 62 Pemphigus 62 AREDS 62 Successfully Treated 62 Nonalcoholic Steatohepatitis 62 Oral Cavity 62 vitreous floaters 62 Hepatitis C Genotype 62 Resistant Hypertension 62 Bladder Cancer 62 Heart Transplant Recipients 62 Exacerbations 62 Lung Cancer Survival 62 Gum Disease 62 Aggressive Prostate Cancer 62 Colorectal Cancers 62 Valvular Heart Disease 62 Strabismus 61 Migraine Headaches 61 Respiratory Infections 61 Patients Undergoing 61 retinal vein occlusion 61 Lung Cancer Patients 61 Effective Treatments 61 Postmenopausal Women 61 Demonstrates Efficacy 61 Adjunctive Therapy 61 Breast Cancer Treatment 61 Psychiatric Disorders 61 Cardiovascular Risk Reduction 61 Radiofrequency Ablation 61 Refractory Angina 61 Peripheral Arterial Disease 61 Renal Cell Carcinoma RCC 61 glaucoma diabetic retinopathy 61 Chronic Lymphocytic Leukemia CLL 61 STRIDE PD 61 Therapeutic Effects 61 Dual Antiplatelet Therapy 61 Sustained Reduction 61 Relapsing Multiple Sclerosis 61 Rheumatoid Arthritis 61 Kidney Failure 61 Antiviral Therapy 61 Observational Study 61 Artificial Pancreas 61 Growth Hormone Deficiency 61 Glucose Monitoring 61 Drug Prevents 61 glaucoma cataract 61 Cardiovascular Risk 61 Preclinical Efficacy 61 Systemic Lupus Erythematosus 61 Better Outcomes 61 Mitral Regurgitation 61 Brain Scans 61 Orphan Diseases 61 Complicated Skin 61 Stem Cell Transplants 61 Cognitive Decline 61 Advanced Renal Cell 61 Pediatric Patients 61 Combo Therapy 61 Leber congenital amaurosis LCA 61 Cancer Therapies 61 Slows Progression 61 Endometrial Cancer 61 Diastolic Heart Failure 61 Cholesterol Levels 61 Artery Disease 61 Drug Candidate 61 Prostatectomy 61 Rheumatoid 61 Therapeutic Targets 61 Shows Promise Against 61 Coronary Arteries 61 Recurrent Breast Cancer 61 Functional Outcomes 61 Meningiomas 61 Antipsychotic Medications 61 Statin Therapy 61 Thrombus 61 Mucositis 61 Astigmatism 61 Cancer Stem Cells 61 Combination Treatment 61 Insulin Therapy 61 B Cell Lymphoma 61 Coronary Disease 61 Cardiovascular Disease Risk 61 Efficacious 61 Neoplasms 61 Ischaemic 61 Viral Infections 61 Elderly Patients 61 Malignant Glioma 61 Oral Mucositis 61 Patients Suffering 61 retinopathy 61 Prostate Cancer Treatment 61 Lupus Drug 61 evaporative dry 61 Short Stature 61 T1DM 61 Endovascular Treatment 61 FDA Approves Drug 61 Eye Infections 61 Nearsightedness 61 Meta Analysis 61 Islet Transplantation 61 Dialysis Outcomes 61 Erythropoietic 61 Transplant Rejection 61 Sinus Infections 61 Atypical Hemolytic Uremic Syndrome 61 Leukemias 61 Cell Transplants 61 Reduced Risk 61 retinal dystrophies 61 Patient Enrollment 61 Chronic Wounds 61 Uterine Fibroid Embolization 61 CYT# potent vascular disrupting 61 Bone Metastases 61 Adjuvant Chemotherapy 61 Osteoarthritis Patients 61 Image Guided 61 diabetes mellitus DM 61 Neoadjuvant Chemotherapy 61 Renal Anemia 61 Neovascularization 61 Intervention Trial 61 Treatable 61 Hematological 61 CT Angiography 61 Inflammatory Arthritis 61 Inhaled Corticosteroids 61 geographic atrophy 61 Statin Drugs 61 Genetic Variations 61 Immunologic 61 juvenile idiopathic arthritis 61 Inhaled Steroids 61 Total Knee Arthroplasty 61 Dupuytren Disease 61 Pivotal Trial 61 LUMINATE 61 Treatment Approaches 61 Improves Survival 61 Intracranial Aneurysms 61 Renal Disease 61 Thromboembolic 60 irreversible blindness 60 Brain Atrophy 60 Enzyme Replacement Therapy 60 Inflammatory Bowel Diseases 60 Guidelines Issued 60 Chronic Myelogenous Leukemia 60 Endothelial 60 Arrhythmias 60 Fecal Incontinence 60 Unresectable 60 Acute Coronary Syndromes 60 Hormone Refractory Prostate Cancer 60 Cholesterol Levels SPARCL 60 Peptic Ulcer 60 Bloodstream Infections 60 Randomized Controlled Trials 60 Neurodegenerative Disease 60 Anticoagulants 60 leiomyomas 60 Novel Therapies 60 Phase Ib Clinical Trial 60 ST Elevation Myocardial 60 Post Operative 60 Diabetes Mellitus 60 Metastases 60 Investigational Agent 60 Brain Tumors 60 Rheumatoid Arthritis Drug 60 Adult Stem Cell Therapy 60 Randomized Clinical Trial 60 Ventricular Tachycardia 60 vWD 60 Proves Effective 60 Premature Infants 60 Alternative Treatments 60 Multicenter Trial 60 See CLINICAL PHARMACOLOGY 60 macular edema 60 Genital Herpes 60 Venous Thromboembolism VTE 60 Relapsed Multiple Myeloma 60 Percutaneous Tibial Nerve Stimulation 60 Insulin Sensitivity 60 Skin Cancers 60 Neuroendocrine Tumors 60 Antiplatelet Therapy 60 Hospital Acquired Pneumonia 60 Generalized Anxiety Disorder 60 Acute Exacerbations 60 Neuroprotection 60 Psoriatic Arthritis 60 Sinus Surgery 60 Thyroid Hormone 60 Improved Survival 60 Lung Cancer Drug 60 Juvenile Idiopathic Arthritis JIA 60 Metastatic Colorectal Cancer 60 Systemic Lupus Erythematosus SLE 60 CRVO 60 Corneal Transplant 60 Skeletal Muscle 60 Autoimmune Disorders 60 Barrett Esophagus 60 Protein Linked 60 Sleep Disturbances 60 Respiratory Distress 60 Gene Variants 60 Chemotherapeutic Agents 60 Reduces Mortality 60 Uterine Fibroid 60 Completes Patient Enrollment 60 Inflammatory Bowel Disease 60 Blood Pressure Drug 60 Retinal Disease 60 Optical Coherence Tomography 60 Anti Tumor Activity 60 progressive neurodegenerative disorder 60 Gene Mutations 60 Genes Associated 60 Ventricular Arrhythmias 60 RNAi Therapeutics 60 Presbyopia 60 Postherpetic Neuralgia 60 Endothelial Function 60 Ankylosing Spondylitis 60 Previously Treated 60 Ocular Hypertension 60 Differential Diagnosis 60 HeFH 60 Preterm Delivery 60 Novel Oral 60 Thiazolidinediones 60 Endovascular Repair 60 Hypertriglyceridemia 60 Systematic Review 60 Visceral Fat 60 Chronic Insomnia 60 Thyroid Cancer 60 Controlled Study 60 Enlarged Prostate 60 INS# [001] 60 strabismus crossed 60 Stomach Cancer 60 Soft Tissue Sarcoma 60 Depressive Symptoms 60 Kidney Transplants 60 Prophylactic Treatment 60 Outpatient Setting 60 Antifungals 60 Treating Depression 60 Genes Predict 60 Physician Insights 60 Irritable Bowel 60 Cardiometabolic 60 Chemotherapy induced 60 Hepatitis C Treatment 60 Clinical Relevance 60 Localized Prostate Cancer 60 limbal stem cell 60 Genes Involved 60 Epidermal Growth Factor Receptor 60 Iron Deficiency Anemia 60 Spinal Fusion 60 postoperative atrial fibrillation 60 Antibiotic Treatment 60 Cognitive Function 60 Vitamin D Deficiency 60 Hip Fractures 60 LDL Cholesterol 60 Chronic Hepatitis C 60 Naive Patients 60 Medication Adherence 60 Parkinson Disease PD 60 Excessive Sweating 60 Sustained Efficacy 60 Lifestyle Intervention 60 Progenitor Cells 60 First Patient Enrolled 60 Circulating Tumor Cells 60 Adjuvant Treatment 60 Stress Urinary Incontinence 60 central retinal vein 60 Myelodysplastic Syndrome MDS 60 Arterial Disease 60 diabetic microvascular complications 60 Mouse Models 60 Interferon Beta 60 Hyperuricemia 60 Lung Cancer Trial 60 refractive error 60 Cachexia 60 Trigeminal Neuralgia 60 Hematologic 60 Cochlear Implants 60 Lower Limb 60 Nicotine Vaccine 60 Kidney Disease 60 conjunctival hyperemia 60 Sjogren Syndrome 60 Metabolic Syndrome 60 transcranial Doppler ultrasound 60 Statistically Significant 60 metastatic neuroendocrine tumors 60 Novel Mechanism 60 complement inhibitor eculizumab 60 Clinically Significant 60 Otitis Media 60 Colorectal Cancer Patients 60 Acute Coronary Syndromes ACS 60 Aortic stenosis 60 Hypotension 60 Venous Thrombosis 60 Chronic Fatigue Syndrome CFS 60 Retreatment 60 neovascular form 60 Eye Exams 60 Dyslipidemia 60 Virus Infection 60 Serious Infections 60 Monoclonal Antibodies 60 SHPT 60 Childhood Asthma 60 Breast Density 60 Portal Hypertension 60 Major Depressive Disorder 60 familial amyloidotic polyneuropathy FAP 60 Golimumab 60 INCB# [003] 60 Immune Responses 60 Osteoporotic 60 Genetic Disorders 60 Relapsed Refractory 60 Microalbuminuria 60 elevated intraocular pressure 60 Renal Cell Cancer 60 demyelinating 60 Protein Involved 60 ARMD 60 giant cell arteritis 60 Liver Cancer 60 Tumor Response 60 Melasma 60 Nymox NX 60 Reperfusion Injury 59 prematurity ROP 59 Undiagnosed 59 Breast Carcinoma 59 Synaptic Plasticity 59 Breast Ultrasound 59 Anticoagulation 59 atherothrombosis 59 Tumor Growth 59 Stakeholder Opinions 59 CP CPPS 59 Bipolar Disorders 59 Randomized Double blind 59 PET Scans 59 Squamous 59 Bacterial Infections 59 Survival Rates 59 Clinical Validation 59 Novel Therapeutic 59 Beta Blocker 59 Effectively Treats 59 Hypertensive Patients 59 diabetic nephropathy 59 Bladder Control 59 Gene Mutation Linked 59 Study Demonstrates 59 Irritable Bowel Syndrome IBS 59 Lumbar Spine 59 pulmonary hypertension PH 59 ExTRACT TIMI 59 Skin Disorders 59 predominantly classic subfoveal 59 nonarteritic anterior ischemic optic 59 Protease Inhibitors 59 Diabetic nephropathy 59 Phase III Trials 59 Liver Metastases 59 Non Alcoholic Steatohepatitis 59 Hedgehog Pathway Inhibitor 59 urolithiasis 59 Newly Diagnosed 59 Immune Cell 59 corneal ectasia 59 Retisert TM 59 post thrombotic syndrome 59 deCODE Glaucoma TM 59 Myelodysplastic syndromes MDS 59 Renal Impairment 59 Basal Cell Carcinoma 59 Prognostic Significance 59 atypical Hemolytic Uremic Syndrome 59 Asymptomatic 59 ANN INTERN MED 59 Hemodialysis Patients 59 kidney urologic 59 Etiology 59 Anticoagulant 59 Muscle Wasting 59 Erosive 59 Key Attributes 59 FDA Approvals 59 Phase IIb Clinical Trial 59 Kidney Stones 59 Anti VEGF 59 Minimally Invasive Procedure 59 II Clinical Trial 59 Organ Rejection 59 Bronchoscopy 59 Glatiramer Acetate 59 Endothelial Dysfunction 59 Chronic Liver Disease 59 Panic Disorder 59 Hyperkalemia 59 Psoriasis Patients 59 Cutaneous T 59 Premature Aging 59 Appears Safe 59 Orthostatic Hypotension 59 PresbyLens ® 59 Vertebral Compression Fractures 59 Decompensated Heart Failure 59 Breast Tumors 59 Smoking Linked 59 Acute Myocardial 59 Hematological Malignancies 59 Echocardiographic 59 Non Invasive 59 Radical Prostatectomy 59 Carotid Artery 59 Alemtuzumab 59 Test Detects 59 Gestational Diabetes 59 Ranibizumab 59 Pivotal Clinical Trial 59 Advanced Pancreatic Cancer 59 variceal bleeding 59 JAK2 Inhibitor 59 Demonstrates Positive 59 MMR Vaccine 59 Thrombotic 59 Chronic Kidney 59 Retinitis Pigmentosa 59 Idiopathic Pulmonary Fibrosis 59 Retinoblastoma 59 Successfully Treats 59 Targeted Therapy 59 Thrombocytopenia 59 Less Invasive 59 Lung Function 59 Stenosis 59 Genetic Basis 59 overactive bladder syndrome 59 Premenopausal Women 59 Aortic Stenosis 59 Demonstrates Significant 59 cutaneous squamous cell carcinoma 59 Kidney Transplant Patients 59 Diabetic Macular Edema DME 59 Lesion 59 Esophageal 59 Helps Predict 59 SJIA 59 Amblyopia 59 Topical Treatment 59 Spasticity 59 Proliferative 59 Critically Ill Patients 59 Valve Replacement 59 Bipolar Depression 59 Aortic Aneurysms 59 Bisphosphonate 59 systemic fungal infections 59 glaucomatous 59 Reduce Mortality 59 Novel Approaches 59 Lysosomal 59 Myelofibrosis 59 Vaccine Candidate 59 Suicidality 59 Left Ventricular Dysfunction 59 Parathyroid 59 Thromboembolism 59 Helps Diagnose 59 Clinical Trial Evaluating 59 Estrogen Therapy 59 Hemorrhagic Stroke 59 Investigational Drug 59 Bone Fractures 59 Gene Variant 59 Acute Myocardial Infarction 59 Diabetic Kidney Disease 59 Phase 2b Study 59 Adjuvant Therapy 59 Retinal 59 Sudden Cardiac Death 59 von Willebrand Disease 59 Showed Significant 59 Lipodystrophy 59 chronic thromboembolic pulmonary 59 Treatment Regimen 59 Sleep Disordered Breathing 59 Dementia Risk 59 Metastatic Renal Cell Carcinoma 59 Rheumatologists 59 T2DM 59 Lung Tumors 59 Hepatotoxicity 59 HIV HCV coinfected 59 Intracerebral Hemorrhage 59 Polycystic Ovary Syndrome 59 Breast Tissue 59 Complications Trial 59 Pneumococcal Vaccine 59 Pivotal Phase III 59 Hypertrophic 59 Carcinomas 59 Cell Lymphoma 59 Calcium Intake 59 Leber Congenital Amaurosis LCA 59 Genetic Mutations 59 Pervasive Developmental Disorders 59 Bucindolol 59 Cholesterol Lowering Drug 59 Advanced Colorectal Cancer 59 Diabetic Retinopathy DR 59 Obese Patients 59 Controlled Trial 59 Tiotropium 59 Analytical Tool 59 Drug Eluting 59 inherited retinal 59 paroxysmal nocturnal hemoglobinuria 59 Protease Inhibitor 59 FOLOTYN ® 59 retinal disorders 59 Risk Stratification 59 Varicose Veins 59 Stroke Risk 59 Prostate Biopsy 59 Safinamide 59 Osteoporosis Drugs 59 pegaptanib 59 Shows Promising 59 Etanercept 59 Inflammatory Bowel 59 Hemolysis 59 Placebo Controlled Study 59 Preclinical Data 59 Therapeutic Apheresis 59 Chronic Cough 59 Symptom Relief 59 Vitamin D Linked 59 Atherosclerosis 59 Blocked Arteries 59 Prognostic Factors 59 Lung Cancers 59 Treatment Outcomes 59 HER2 Positive Breast Cancer 59 Chronic Pelvic Pain 59 Urodynamics 59 PAOD 59 Fibromyalgia Pain 59 Infarct 59 Ear Infections 59 Esophageal Cancer 59 Pre Eclampsia 59 wet macular degeneration 59 Blood Cancers 59 Osteoporosis Treatment 59 Peripheral Blood 59 Diabetes Hypertension 59 Drug Combo 59 retinitis pigmentosa RP 59 Cardiovascular Events 59 Ischemia 59 Synthetic Peptide 59 Diagnostic Tests 59 Therapeutic Antibody 59 Predict Breast Cancer 59 Treating Prostate Cancer 59 lichen planus 59 Prospective Randomized Double 59 Hp2 2 59 Elagolix 59 Urinary Tract Infections 59 Diabetes Interventions 59 Unfractionated Heparin 59 Pituitary 59 Diagnosis Treatment 59 Molecular Basis 59 related Macular Degeneration 59 multisystem disease 59 Restless Legs Syndrome RLS 59 Novel Therapeutics 59 Cardiac Arrhythmias 58 Kinase Inhibitors 58 Pleural Mesothelioma 58 Dendritic Cells 58 Angiographic 58 Innate Immune 58 Diagnostic Assay 58 Metabolic Endocrinology 58 Device Helps 58 Community Acquired Pneumonia 58 Congestive Heart Failure 58 Insulin Delivery 58 Muscle Function 58 Lymphocytic 58 Watchful Waiting 58 acute PAO 58 Idiopathic 58 Glucose Metabolism 58 Psychological Distress 58 Papillary 58 Lymph Nodes 58 Prolongs Life 58 Preclinical Study 58 Artificial Cornea 58 Receives Orphan Drug Designation 58 diabetic retinopathy macular degeneration 58 Stent Implantation 58 neovascular diseases 58 Tumor Microenvironment 58 Denufosol 58 retinal degeneration 58 Nilotinib 58 Uric Acid 58 Breast Cancer Cells 58 optic neuropathy 58 Malignant Pleural Mesothelioma 58 Stent Placement 58 LASEK 58 Liver Tumors 58 overt nephropathy 58 Toxicogenomics 58 Obese Teens 58 Ulcerative Colitis 58 Long Term Efficacy 58 Lung Transplants 58 Cancer Immunotherapy 58 Stress Induced 58 Mitochondrial Dysfunction 58 intravitreal injections 58 Viral Load 58 Keratosis 58 Dialysis Patients 58 Cervical Spine 58 CABG Surgery 58 transthyretin TTR mediated amyloidosis 58 Lung Cancer Treatment 58 EVIZON TM 58 Therapy Shows Promise 58 Cause Mortality 58 Decitabine 58 Brain Aneurysms 58 Patient Registry 58 posterior uveitis 58 Long Term Outcomes 58 treat benign prostatic 58 Androgen Deprivation Therapy 58 Cholangiocarcinoma 58 Antidepressants Linked 58 Arteriosclerosis 58 Pancreatic 58 lupus erythematosus 58 POAG 58 Viral Suppression 58 Cardiac Marker 58 Diabetic Peripheral Neuropathy 58 Improve Diagnosis 58 Balloon Kyphoplasty 58 Pathogenesis 58 Screening Mammography 58 Photodynamic Therapy 58 Malaria Vaccine 58 INSPIRE Trial Phase III 58 artery stenosis 58 Demonstrates Sustained 58 Schizophrenia Treatment 58 TB Vaccine 58 Prostate Cancers 58 Combination Therapy 58 toenail onychomycosis 58 GI motility disorders 58 ruboxistaurin 58 Vitreoretinal 58 Acne Rosacea 58 Pancreas Cancer 58 Bone Marrow Transplants 58 MR Angiography 58 Proteinuria 58 Prostate Cancer Risk 58 Neurodegenerative diseases 58 relapsing remitting MS RRMS 58 Cancer Recurrence 58 Initiates Clinical 58 Aurora Kinase 58 Double Blind Placebo 58 Subarachnoid hemorrhage 58 Neurostimulation 58 Total Knee Replacement 58 Vitamin D Levels 58 hypovitaminosis D 58 Hyperparathyroidism 58 Immunotherapeutic 58 Cancer Treatments 58 Prevalence Estimates 58 Genetic Variants 58 Mitral Valve Repair 58 Acute Treatment 58 Arthritis Musculoskeletal 58 ORLive Presents 58 Electrical Stimulation 58 Diabetic Foot 58 SNT MC#